Mersana Therapeutics, Inc. (MRSN)
USD 1.69
(-16.75%)
USD 1.69
(-16.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -168.88 Million | -49.36 Million | -139.98 Million | -74.69 Million | -67.74 Million | -55.21 Million |
| Net Income | -171.67 Million | -204.21 Million | -170.06 Million | -88.04 Million | -28.2 Million | -64.25 Million |
| Depreciation & Amortization | 1.51 Million | 927 Thousand | 855 Thousand | 1.01 Million | 1.24 Million | 1.25 Million |
| Deferred income taxes | -23.92 Million | - | - | -86 Thousand | -222 Thousand | -386 Thousand |
| Stock-based compensation | 21.13 Million | 21.52 Million | 18.4 Million | 7.17 Million | 4.87 Million | 3.88 Million |
| Change in working capital | -18.76 Million | 133.09 Million | 10.08 Million | 5.1 Million | -45.53 Million | 4.17 Million |
| Other non-cash items | 22.81 Million | -699 Thousand | 723 Thousand | 148 Thousand | 103 Thousand | 110 Thousand |
| Investing Cash Flow | 119.88 Million | -152.71 Million | -648 Thousand | 37.02 Million | -27.29 Million | 87.19 Million |
| Investments in PPE | -2.16 Million | -2.19 Million | -648 Thousand | -473 Thousand | -605 Thousand | -1.37 Million |
| Acquisitions | - | 150.51 Million | - | - | 26.68 Million | - |
| Investment purchases | -155.91 Million | -247.51 Million | - | - | -53.68 Million | - |
| Sales/Maturities of investments | 277.97 Million | 97 Million | - | 37.5 Million | 27 Million | 88.56 Million |
| Other Investing Activities | 122.05 Million | -150.51 Million | - | 37.5 Million | -26.68 Million | 88.56 Million |
| Financing Cash Flow | 94.67 Million | 153.01 Million | 63.64 Million | 230.41 Million | 97.7 Million | 1.06 Million |
| Debt repayment | -93.12 Million | -272 Thousand | -5.7 Million | -313 Thousand | -87 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 1.12 Million | 1.06 Million | 640 Thousand | 561 Thousand | 489 Thousand | 146 Thousand |
| Common Stock Issuance | 1.54 Million | 2.39 Million | 43.08 Million | 227.02 Million | 92.16 Million | 1.06 Million |
| Other Financing Activities | 94.93 Million | 153.28 Million | 25.62 Million | 3.13 Million | 5.14 Million | 1.06 Million |
| Accounts receivables | 30 Million | -30 Million | - | - | 459 Thousand | 325 Thousand |
| Accounts payables | -6.08 Million | 947 Thousand | 483 Thousand | 942 Thousand | -3.11 Million | 7.37 Million |
| Inventory | - | - | - | - | -1.5 Million | 2.6 Million |
| Other working capital | -42.68 Million | 162.15 Million | 9.6 Million | 4.16 Million | -41.38 Million | -6.13 Million |
| Cash at beginning of period | 128.88 Million | 178.42 Million | 255.41 Million | 62.67 Million | 60 Million | 26.96 Million |
| Cash at end of period | 174.56 Million | 129.36 Million | 178.42 Million | 255.41 Million | 62.67 Million | 60 Million |
| Capital Expenditure | -2.16 Million | -2.19 Million | -648 Thousand | -473 Thousand | -605 Thousand | -1.37 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 45.67 Million | -49.06 Million | -76.99 Million | 192.74 Million | 2.66 Million | 33.04 Million |
| Free Cash Flow | -171.05 Million | -51.56 Million | -140.63 Million | -75.16 Million | -68.34 Million | -56.58 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.26 Million | -19.3 Million | -171.67 Million | -19.54 Million | -41.65 Million | -54.3 Million |
| Depreciation & Amortization | 403 Thousand | 423 Thousand | 1.51 Million | 447 Thousand | 427 Thousand | 324 Thousand |
| Deferred income taxes | - | - | -23.92 Million | 2.82 Million | -1.04 Million | -1.78 Million |
| Stock-based compensation | 4.42 Million | 4.66 Million | 21.13 Million | 4.08 Million | 4 Million | 6.64 Million |
| Change in working capital | -1.98 Million | -18.13 Million | -18.76 Million | -21.73 Million | -8.02 Million | -12.88 Million |
| Other non-cash items | 6.37 Million | 9.37 Million | 22.81 Million | -227 Thousand | 217 Thousand | 167 Thousand |
| Investing Cash Flow | 5.51 Million | -72.54 Million | 119.88 Million | 20.14 Million | 103.77 Million | -5.43 Million |
| Investments in PPE | - | -132 Thousand | -2.16 Million | -386 Thousand | -472 Thousand | -399 Thousand |
| Acquisitions | - | - | - | 101.51 Million | -104.25 Million | 5.04 Million |
| Investment purchases | -19.48 Million | -87.41 Million | -155.91 Million | -24.46 Million | -9.72 Million | -58.04 Million |
| Sales/Maturities of investments | 25 Million | 15 Million | 277.97 Million | 45 Million | 113.97 Million | 53 Million |
| Other Investing Activities | 5.51 Million | -72.41 Million | 122.05 Million | -101.51 Million | 104.25 Million | -5.04 Million |
| Financing Cash Flow | 153 Thousand | 5.82 Million | 94.67 Million | 92 Thousand | -146 Thousand | 73.18 Million |
| Debt repayment | -113 Thousand | -5.78 Million | -93.12 Million | -66 Thousand | -146 Thousand | -71.82 Million |
| Dividends payments | - | - | - | -227 Thousand | - | - |
| Common Stock Repurchased | - | - | 1.12 Million | 1.2 Million | -81 Thousand | - |
| Common Stock Issuance | 266 Thousand | 48 Thousand | 1.54 Million | 158 Thousand | -81 Thousand | 1.35 Million |
| Other Financing Activities | 200 Thousand | 5.89 Million | 94.93 Million | 92 Thousand | -65 Thousand | 73.18 Million |
| Accounts receivables | -1.57 Million | - | 30 Million | - | - | - |
| Accounts payables | -8000.00 | -4.16 Million | -6.08 Million | -5.42 Million | -3.99 Million | -1.39 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -402 Thousand | -13.96 Million | -42.68 Million | -16.31 Million | -4.02 Million | -11.49 Million |
| Cash at beginning of period | 75.18 Million | 174.56 Million | 128.88 Million | 186.28 Million | 129.21 Million | 123.3 Million |
| Cash at end of period | 58.99 Million | 75.18 Million | 174.56 Million | 174.56 Million | 186.76 Million | 129.21 Million |
| Capital Expenditure | - | -132 Thousand | -2.16 Million | -386 Thousand | -472 Thousand | -399 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -16.18 Million | -99.37 Million | 45.67 Million | -11.72 Million | 57.55 Million | 5.9 Million |
| Free Cash Flow | -21.85 Million | -32.78 Million | -171.05 Million | -34.53 Million | -46.55 Million | -62.23 Million |
2330
NNAX
GV
0433
KK
LES